Korro Bio (KRRO) Minority Interest (2018 - 2019)

Korro Bio's (KRRO) quarterly Minority Interest came in at $3.8 million in Q3 2019, little changed on a QoQ basis from $3.8 million in Q4 2018.

Korro Bio (KRRO) Minority Interest (2018 - 2019) Analysis & Trends

Korro Bio (KRRO) has 2 years of Minority Interest data on file, last reported at $3.8 million in Q3 2019.

Quarterly Minority Interest changed N/A year-over-year to $3.8 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $3.8 million (changed N/A YoY) and the FY2018 annual result came in at $3.8 million, changed N/A from the prior year.
Minority Interest held at $3.8 million in Q3 2019, from $3.8 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $3.8 million in Q4 2018 to a low of $3.8 million in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Korro Bio	231.77 Mn	116.73 Mn	-

Download Data

Date	Value
Sep 30, 2019	3.77 Mn
Dec 31, 2018	3.77 Mn